Publication | Closed Access

Oroxin B selectively induces tumor-suppressive ER stress and concurrently inhibits tumor-adaptive ER stress in B-lymphoma cells for effective anti-lymphoma therapy

Cancer ResearchLymphoid NeoplasiaImmunologyImmune Checkpoint InhibitorAnti-cancer AgentB-lymphoma CellsMedicineCell BiologyOroxin BTumor BiologyTumor-adaptive Er Stress